Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial

CONTEXT Intravenous tissue-type plasminogen activator can be beneficial to some patients when given within 3 hours of stroke onset, but many patients present later after stroke onset and alternative treatments are needed. OBJECTIVE To determine the clinical efficacy and safety of intra-arterial (IA)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 1999-12, Vol.282 (21), p.2003-2011
Hauptverfasser: Furlan, Anthony, Higashida, Randall, Wechsler, Lawrence, Gent, Michael, Rowley, Howard, Kase, Carlos, Pessin, Michael, Ahuja, Arvind, Callahan, Fred, Clark, Wayne M, Silver, Frank, Rivera, Frank, for the PROACT Investigators
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!